Scarica l'app Stockscreener
4.40
3.93%
-0.18
Dopo l'orario di chiusura:
4.42
0.02
+0.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.58
Aprire:
$4.56
Volume 24 ore:
353.73K
Relative Volume:
0.59
Capitalizzazione di mercato:
$234.23M
Reddito:
-
Utile/perdita netta:
$-32.94M
Rapporto P/E:
-3.964
EPS:
-1.11
Flusso di cassa netto:
$-24.95M
1 W Prestazione:
-6.98%
1M Prestazione:
+11.39%
6M Prestazione:
+55.48%
1 anno Prestazione:
+52.78%
Intervallo 1D:
$4.38
$4.64
Intervallo di 1 settimana:
$4.31
$4.70
Portata 52W:
$1.84
$6.025
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
4.40 | 243.81M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-25 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-08-21 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
Achieve Life Sciences outlines Late-breaking survey results on ORCA-OL unveiled - Traders Union
Achieve Life Sciences, Inc. $ACHV Shares Sold by Propel Bio Management LLC - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Achieve Life Sciences presents cytisinicline quit-smoking data - Investing.com
Achieve Life Sciences Presents Data at SRNT Demonstrating - GlobeNewswire
ACHV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Achieve Life Sciences (ACHV) Expected to Announce Earnings on Tuesday - MarketBeat
Caris Life Sciences Completes Interim Readout of Achieve 1 Study - Finviz
Achieve Life Sciences, Inc. advances new smoking cessation treatment as over 16 million Americans face heart disease - Traders Union
Achieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving AverageWhat's Next? - MarketBeat
ACHV SEC FilingsAchieve Life Sciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
What is Achieve Life Sciences Inc.’s book value per sharePortfolio Value Report & Real-Time Stock Entry Alerts - mfd.ru
Aug Reactions: Whats the MACD signal for Achieve Life Sciences Inc2025 Macro Impact & Smart Money Movement Alerts - baoquankhu1.vn
Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering - MSN
Is Achieve Life Sciences Inc. stock trending bullishWeekly Loss Report & Fast Momentum Entry Tips - mfd.ru
Achieve Life Sciences appoints Oki as Chief Financial Officer - Intellectia AI
What are Achieve Life Sciences Inc.’s recent SEC filings showingGlobal Markets & Precise Buy Zone Identification - mfd.ru
Why Achieve Life Sciences Inc. stock appeals to dividend seekers2025 Analyst Calls & Long-Term Growth Stock Strategies - mfd.ru
Alert wrongly tagged to Achieve Life Sciences withdrawn - marketscreener.com
Will Achieve Life Sciences Inc. (SP4P) stock outperform small cap peersEarnings Risk Summary & Low Risk Entry Point Guides - mfd.ru
IPO Launch: What are Achieve Life Sciences Incs recent SEC filings showingQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Roivant Sciences (ROIV) - The Globe and Mail
Chipmakers Recap: What’s the profit margin of Achieve Life Sciences IncJuly 2025 Final Week & Real-Time Stock Movement Alerts - baoquankhu1.vn
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
Franklin Resources Inc's Strategic Acquisition of Achieve Life S - GuruFocus
Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch - Seeking Alpha
Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026Strong Buy - Seeking Alpha
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory - Finviz
Achieve Life Sciences Announced Granting of New Hire Inducement Awards - The Manila Times
Five new hires at Achieve Life Sciences get 115,000 stock options - Stock Titan
Retail Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) Market Cap Dropped by US$56m - 富途牛牛
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
What is HC Wainwright's Estimate for ACHV FY2026 Earnings? - MarketBeat
FY2030 Earnings Forecast for ACHV Issued By HC Wainwright - Defense World
What is HC Wainwright's Forecast for ACHV FY2030 Earnings? - MarketBeat
Achieve Life Sciences may offer up to $300 million in securities - marketscreener.com
Achieve Life Sciences May Offer Up To $300 Million In Securities - TradingView
Achieve Life Sciences (ACHV) Announces $300M Securities Shelf Registration - GuruFocus
Achieve Life Sciences Files $300 Million Mixed Shelf - marketscreener.com
Portfolio Update: What are Achieve Life Sciences Incs recent SEC filings showingTrade Risk Assessment & Stepwise Swing Trade Plans - baoquankhu1.vn
Fed Watch: Will Achieve Life Sciences Inc benefit from sector rotationJuly 2025 Review & Stepwise Trade Signal Guides - baoquankhu1.vn
Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Aug PostEarnings: Is Achieve Life Sciences Inc stock trending bullishPortfolio Return Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Quarterly Earnings: Is Achieve Life Sciences Inc forming a breakout patternShort Setup & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future - Yahoo Finance
Whats the fair value of Achieve Life Sciences Inc stockAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Achieve Life Sciences’ smoking treatment likely to be approved by FDA, says Hunterbrook - MSN
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Achieve Life Sciences Inc Azioni (ACHV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Oki Mark K | Chief Financial Officer |
Sep 18 '25 |
Sale |
2.92 |
50,060 |
146,175 |
127,940 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Option Exercise |
0.00 |
297,500 |
0 |
358,376 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Sale |
2.92 |
129,501 |
378,143 |
228,875 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
34,100 |
0 |
46,764 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Sale |
2.77 |
14,070 |
38,974 |
32,694 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Option Exercise |
0.00 |
455,000 |
0 |
455,000 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Sale |
2.77 |
139,858 |
387,407 |
315,142 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Option Exercise |
0.00 |
110,000 |
0 |
143,214 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Sale |
2.77 |
27,629 |
76,532 |
115,585 |
| Xinos Jaime | Chief Commercial Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
69,000 |
0 |
95,286 |
3.69%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):